Key result
There was no overall relationship between diet quality and antihypertensive medication intensity, though an inverse association was seen in younger, lower-risk adults.
Why the study?
Whether diet and medication are used complementarily for high blood pressure management in metabolic syndrome had never been evaluated in real-world settings.
Is there a relationship between diet quality and antihypertensive medication intensity among adults with metabolic syndrome-associated high blood pressure?
Cross-Sectional (n=915)
Is there a relationship between diet quality and antihypertensive medication intensity among adults with metabolic syndrome-associated high blood pressure?
Answers are grounded in this paper and cite their sources.
In adults with metabolic syndrome-associated high blood pressure, diet quality and BP-lowering medication do not appear to be used complementarily, with younger and lower-risk individuals showing an inverse relationship between diet quality and medication intensity.
BackgroundManagement of high blood pressure (BP), one of the key feature of the metabolic syndrome (MetS), relies on diet and medication. Whether these modalities are used as complements has never been evaluated in real-world settings. This study assessed the relationship between diet quality and antihypertensive medication intensity among adults with MetS-associated high BP.MethodsThis cross-sectional study included 915 adults with MetS-associated high BP from the CARTaGENE cohort (Quebec, Canada), of which 677 reported using BP-lowering medication. Antihypertensive medication intensity was graded per the number of BP-lowering classes used simultaneously. Diet quality was assessed using the DASH score.ResultsNo evidence of a relationship between antihypertensive medication intensity and diet quality was found (β for each additional antihypertensive=-0.05, 95%CI: -0.35, 0.26 DASH score points). However, among male/men aged <50 years and female/women aged <60 years, the DASH score was inversely associated with medication intensity (β=-0.72, 95%CI: -1.24, -0.19), while this relationship tended to be positive among older participants (β=0.32, 95%CI: -0.05, 0.69). Among participants with low Framingham risk score, the DASH score was inversely associated with medication intensity (β=-0.70, 95%CI: -1.31, -0.09), but no evidence of an association was found among individuals at moderate (β=0.00, 95%CI: -0.45, 0.45) or high (β=0.30, 95%CI: -0.24, 0.84) risk.ConclusionIn this cohort of adults with MetS-associated high BP, there was an overall lack of complementarity between diet quality and BP-lowering medication, especially among younger individuals and those with a lower CVD risk, for whom diet quality was inversely associated with medication intensity.
No takes yet. Share an insight, caveat, or question.
Leblay et al. (2023) conducted a cross-sectional in Metabolic Syndrome-Associated High Blood Pressure (n=915). Diet quality (DASH score) vs. Antihypertensive medication intensity was evaluated on Relationship between diet quality and antihypertensive medication intensity (β -0.05, 95% CI -0.35, 0.26). There was no overall relationship between diet quality and antihypertensive medication intensity, though an inverse association was seen in younger, lower-risk adults.
Synapse has enriched 10 related papers. Consider them for comparative context: